Download PDF FlyerAbstract
The excellent innovative work of Squibb Laboratory scientists in the 1970’s led to the discovery of the ACE inhibitors and the ARBs. Despite their widespread use, for renoprotection, we have continued to experience a global ESRD pandemic. Angiotensin blockade has proved inadequate. In 2010, we asked the rhetorical question: Is renoprotection with RAAS blockade a failed paradigm?
Keywords: Angiotensin receptor blockers, ACE inhibitors, chronic kidney disease, diabetes mellitus, novel classification scheme, revisionist view, renoprotection, renoprotective agents.
Related Journals
Current Dentistry
Current Psychopharmacology
Recent Advances in Anti-Infective Drug Discovery
Anti-Infective Agents
Adolescent Psychiatry
Current Aging Science
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current HIV Research
Current Neurovascular Research
Current Respiratory Medicine Reviews
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
